The Department of International Trials of NCGM is organizing an online symposium on the theme “International Clinical Research (Trials) during COVID-19 era: Should we suspend or continue?“.
Session
The new normal for clinical trials
Date: Thursday, 11 March 2021
Time: 15:45-18:35
Chairs: Hamana Mieko, NCGM-DIT and Muchanga Sifa, NCGM-DIT
| Impact of COVID-19 on infectious diseases research (trials) Dr Norio Ohmagari, Director, Disease Control and Prevention Center, NCGM |
| Impact of COVID-19 on cancer clinical trials Dr Kenichi Nakamura, Director, National Cancer Center |
| Clinical trials in resource limited settings: An example of Leishmaniasis East Africa Platform (LEAP) Dr Monique Wasunna, Director DNDi Africa |
